RxDoctor Payments DataLook up a doctor →

Lacey Hill, APRN

Family · Oklahoma City, OKNPI 1255852414

Payments from drug & device makers

$19,723in general payments, 2019–2025

Across 957 payments — averaging $20.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$5K
  • Boehringer Ingelheim$2K
  • GSK$2K
  • Insmed, Inc.$1K
  • Sanofi$1K
  • Baxter Healthcare$895
  • plus $8K from 34 others

What the payments were for

  • Food & beverage$19,59099%
  • Education$1331%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,723 in reported general payments places this provider in the 95th percentile of 2,026 family providers in Oklahoma.

See all family providers in Oklahoma

Medicare billing

Part B allowed, 2024
$126,127
Medicare patients
674
Services billed
1,888

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter590$439,573
OfevNintedanib Esylate26$361,052
Breo ElliptaFluticasone/Vilanterol229$114,602
Breztri AerosphereBudesonide/Glycopyr/Formoterol147$110,385
Fasenra PenBenralizumab11$62,444
Spiriva RespimatTiotropium Bromide60$47,747
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr79$46,654
Stiolto RespimatTiotropium Br/Olodaterol Hcl39$38,137
Arnuity ElliptaFluticasone Furoate83$24,054
SymbicortBudesonide/Formoterol Fumarate72$22,664
Fluticasone-SalmeterolFluticasone Propion/Salmeterol161$19,917
Combivent RespimatIpratropium/Albuterol Sulfate33$15,949
Incruse ElliptaUmeclidinium Bromide38$14,146
Wixela InhubFluticasone Propion/Salmeterol77$10,428
Albuterol Sulfate HfaAlbuterol Sulfate343$8,884

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta, Incruse Ellipta$1,844$639,0291,019 claims
Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat, Combivent Respimat$1,943$462,886158 claims
AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere$4,599$140,635236 claims
MerckDulera$280$8,75321 claims
Teva Pharmaceuticals USA, Inc.Qvar Redihaler$20$4,71613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,026 family providers in Oklahoma.

Other family in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →